Tectonic Therapeutic (TECX) Assets (2017 - 2026)
Tectonic Therapeutic (TECX) posted quarterly Assets of $246.6 million for Q1 2026, down 21.68% year-over-year from $314.8 million in Q1 2025, and down 5.54% quarter-over-quarter from $261.0 million in Q4 2025.
Analysis
Tectonic Therapeutic (TECX) Assets (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Assets for 10 consecutive years, with $246.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets fell 21.68% year-over-year to $246.6 million; the TTM figure through Mar 2026 stood at $246.6 million (down 21.68% YoY), while the FY2025 annual figure was $261.0 million, up 70.72% from the prior year.
- Assets eased to $246.6 million in Q1 2026 per TECX's latest filing, from $261.0 million in the prior quarter.
- Across five years, Assets topped out at $314.8 million in Q1 2025 and bottomed at $39.4 million in Q4 2023.
- Historically, Assets has averaged $172.0 million across 5 years, with a median of $152.9 million in 2024.
- Annual changes were most pronounced in 2023 — Assets sank 62.1% — and 2024, when it soared 288.09%.
- Tectonic Therapeutic's Assets stood at $103.9 million in 2022, then tumbled by 62.1% to $39.4 million in 2023, then jumped by 288.09% to $152.9 million in 2024, then jumped by 70.72% to $261.0 million in 2025, then fell by 5.54% to $246.6 million in 2026.
- Business Quant data shows TECX's Assets at $246.6 million in Q1 2026, $261.0 million in Q4 2025, and $277.0 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 10.96 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.32 Bn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 9.18 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 5.56 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 19.82 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Tectonic Therapeutic | 589.02 Mn | 589.02 Mn | - | 237.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 237.03 Mn |
| Mar 31, 2026 | 246.58 Mn |
| Dec 31, 2025 | 261.04 Mn |
| Sep 30, 2025 | 277.00 Mn |
| Jun 30, 2025 | 295.31 Mn |
| Mar 31, 2025 | 314.83 Mn |
| Dec 31, 2024 | 152.91 Mn |
| Sep 30, 2024 | 168.72 Mn |
| Jun 30, 2024 | 193.91 Mn |
| Mar 31, 2024 | 92.35 Mn |
| Dec 31, 2023 | 39.40 Mn |
| Sep 30, 2023 | 110.52 Mn |
| Jun 30, 2023 | 133.84 Mn |
| Mar 31, 2023 | 83.01 Mn |
| Dec 31, 2022 | 103.95 Mn |
| Sep 30, 2022 | 129.50 Mn |
| Jun 30, 2022 | 146.24 Mn |
| Mar 31, 2022 | 175.34 Mn |
| Dec 31, 2021 | 203.84 Mn |
| Sep 30, 2021 | 216.45 Mn |